Cyrus Biotechnology

Cyrus Biotechnology

Biotechnology software company offering protein modelling and design capabilities.

All edits

Edits on 17 Sep, 2020
Golden AI"Funding autocalculation"
Golden AI edited on 17 Sep, 2020
Edits made to:
Infobox (+1/-1 properties)
Infobox
Total funding amount (USD)
8,000,000
Total funding amount (USD)
9,500,000
Golden AI
Golden AI edited on 17 Sep, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Funding rounds
Cyrus Biotechnology, Inc. funding round, September 2020
Edits on 4 Aug, 2020
Aleksander Holm
Aleksander Holm edited on 4 Aug, 2020
Edits made to:
Infobox (--1 properties)
Infobox
B2X
B2B
Edits on 17 Jul, 2020
Golden AI"Funding autocalculation"
Golden AI edited on 17 Jul, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Total funding amount (USD)
8,000,000
Edits on 20 Feb, 2020
Aime Anne Nisay
Aime Anne Nisay approved a suggestion from Golden's AI on 20 Feb, 2020
Edits made to:
Article (+19/-19 characters)
Article

The company's clients include 10 of the top 20 Global Pharmaceutical firms as well as several smaller biotechnology and chemical firms. Cyrus is financed by several technology and biotechnology investors, including Trinity Ventures, Orbimed, Springrock VenturesSpringrock Ventures, Alexandria Venture Investments, the W Fund, and more.

Edits on 19 Feb, 2020
Golden AI"Adding location topic from lookup Seattle, WA"
Golden AI edited on 19 Feb, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Location
Seattle
Edits on 26 Sep, 2019
Golden AI
Golden AI edited on 26 Sep, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Funding rounds
Cyrus Biotechnology funding round, July 2017
Neelam Jhaveri
Neelam Jhaveri edited on 26 Sep, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 30 May, 2019
Will Suter
Will Suter approved a suggestion from Golden's AI on 30 May, 2019
Edits made to:
Article (+16/-16 characters)
Article

The company's clients include 10 of the top 20 Global Pharmaceutical firms as well as several smaller biotechnology and chemical firms. Cyrus is financed by several technology and biotechnology investors, including Trinity VenturesTrinity Ventures, Orbimed, Springrock Ventures, Alexandria Venture Investments, the W Fund, and more.

Will Suter
Will Suter approved a suggestion from Golden's AI on 30 May, 2019
Edits made to:
Article (+4/-4 characters)
Article

This Software-as-a-Service (SaaSSaaS) product is a platform for protein structure prediction via homology modeling, protein modeling, protein stabilization, protein engineering, and protein design for biologics and small molecules. In July 2018, Cyrus announced that it would release a new immune screening and prediction tool in the platform.

Golden AI
Golden AI edited on 30 May, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Founder
Yifan Song
Golden AI
Golden AI edited on 30 May, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Founder
Lucas Nivon
Golden AI
Golden AI edited on 30 May, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Founder
Javier Castellanos
Edits on 22 Feb, 2019
Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 22 Feb, 2019
Edits made to:
Article (+30/-30 characters)
Article

The company's clients include 10 of the top 20 Global Pharmaceutical firms as well as several smaller biotechnology and chemical firms. Cyrus is financed by several technology and biotechnology investors, including Trinity Ventures, Orbimed, Springrock Ventures, Alexandria Venture InvestmentsAlexandria Venture Investments, the W Fund, and more.

Edits on 16 Feb, 2019
Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 16 Feb, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Industry
Synthetic biology
Edits on 4 Feb, 2019
Tianchang He
Tianchang He approved a suggestion from Golden's AI on 4 Feb, 2019
Edits made to:
Infobox (+4 properties)
People (+10 rows) (+20 cells) (+219 characters)
People

Name
Role
Related Golden topics

Alok Chanani

Investor

Benjamin Baker

Employee

Bryden Robertson

Employee

Craig W Philips

Investor

Gaige Pierce-Raison

Employee

Mary Larrousse

Employee

Michael Monu

Investor

Peter Novotnak

Employee

Ryan Gomoto

Employee

Steven Lewis

Employee

Infobox
Is a
Company
Industry
Biotechnology
Edits on 10 Jan, 2019
Michael Mangus"wrong rosetta"
Michael Mangus edited on 10 Jan, 2019
Edits made to:
Article (+7/-7 characters)
Article

Cyrus Biotechnology is a privately held company based in Seattle, Washington. It offers protein modeling and design capabilities to the biotechnology, pharmaceutical, chemical, consumer products, and synthetic biology industries. The company's primary product is Cyrus Bench, a software package based on RosettaRosetta, a protein-modeling platform created at the University of Washington.

Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 10 Jan, 2019
Edits made to:
Article (+7/-7 characters)
Article

Cyrus Biotechnology is a privately held company based in Seattle, Washington. It offers protein modeling and design capabilities to the biotechnology, pharmaceutical, chemical, consumer products, and synthetic biology industries. The company's primary product is Cyrus Bench, a software package based on RosettaRosetta, a protein-modeling platform created at the University of Washington.

Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 10 Jan, 2019
Edits made to:
Article (+7/-7 characters)
Article

Cyrus Biotechnology is a privately held company based in SeattleSeattle, Washington. It offers protein modeling and design capabilities to the biotechnology, pharmaceutical, chemical, consumer products, and synthetic biology industries. The company's primary product is Cyrus Bench, a software package based on Rosetta, a protein-modeling platform created at the University of Washington.

Edits on 9 Jan, 2019
Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 9 Jan, 2019
Edits made to:
Article (+22/-22 characters)
Article

Cyrus Biotechnology is a privately held companyprivately held company based in Seattle, Washington. It offers protein modeling and design capabilities to the biotechnology, pharmaceutical, chemical, consumer products, and synthetic biology industries. The company's primary product is Cyrus Bench, a software package based on Rosetta, a protein-modeling platform created at the University of Washington.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.